References
Abele-Horn M, Suerbaum S, Frosch M (2002) Evaluierung des Vitek 2 in der Routinediagnostik. Der Mikrobiologe 12:1–13
Funke G, Monnet D, de Bernardis C, von Graevenitz A, Freney J (1998) Evaluation of the Vitek 2 system for rapid identification of medically relevant gram-negative rods. J Clin Microbiol 36:1948–1953
Ligozzi M, Bernini C, Bonora MG, de Fatima M, Zuliani J, Fontana R (2002) Evaluation of the Vitek 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci. J Clin Microbiol 40:1681–1686
Jorgensen JHA, Barry L, Traczewskib VMM, Sahm DF, McElmeel ML, Crawford SA (2000) Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of bioMérieux Vitek 2. J Clin Microbiol 38:2814–2818
Goessens WHF, Lemmens-den Toom N, Hageman J, Hermanns PWM, Sluijter M, de Groot R, Verbrugh HA (2000) Evaluation of the Vitek 2 system for susceptibility testing of Streptococcus pneumoniae isolates. Eur J Clin Microbiol Infect Dis 19:618–622
Livermore DM, Struelens M, Amorim J, Baquero F, Bille J, Canton R, Henning S, Gatermann S, Marchese A, Mittermayer H, Nonhoff C, Oakton KJ, Praplan F, Ramos H, Schito GC, Van Eldere J, Verhaegen J, Verhoef J, Visser MR (2002) Multicentre evaluation of the Vitek 2 advanced expert system for interpretive reading of antimicrobial resistance test. J Antimicrob Chemother 49:289–300
Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing. Approved standard M100-AS15. CLSI, Wayne, Pennsylvania
Funke G, Funke-Kissling P (2005) Performance of the new Vitek 2 GP card for identification of medically relevant gram-positive cocci in a routine clinical laboratory. J Clin Microbiol 43:84–88
Jorgensen JH, Crawford SA, McElmeel LM, Whitney CG (2004) Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the Vitek 2 instrument. J Clin Microbiol 42:5928–5930
Klugmann KP (1996) The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxicillin, and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. J Antimicrob Chemother 38(Suppl A):133–140
Palares R, Linares J, Vadillo M, Cabellos C, Manresa F, Vildarich PF, Martin R, Gudiol F (1995) Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 333:474–480
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abele-Horn, M., Stoy, K., Frosch, M. et al. Comparative evaluation of a new Vitek 2 system for identification and antimicrobial susceptibility testing of Streptococcus pneumoniae . Eur J Clin Microbiol Infect Dis 25, 55–57 (2006). https://doi.org/10.1007/s10096-005-0071-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-005-0071-1